← All stocks

ARS Pharmaceuticals, Inc.

SPRY Scheduled selling only

CIK 0001671858 #3013 in the set updated 19 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$1.95M

$33.55K on a plan · $1.92M straight out of an exercise

Sold at will

$0.00

0 of 5 sales

Net

−$1.95M

$0.00 against sales at will

By person

11 insiders · 5 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Chakma Justin

Chief Business Officer

—

$1.48M (2) scheduled

−$1.48M

0.0000%

$0.00

−100.0%

Karas Eric

Chief Commercial Officer

—

$250.00K (1) scheduled

−$250.00K

12,176

0.0122%

$121.76K

0.0%

Dorsey Brian

Chief Operating Officer

—

$190.05K (1) scheduled

−$190.05K

10,789

0.0108%

$107.89K

0.0%

Fitzpatrick Alexander A

Chief Legal Officer

—

$33.55K (1) scheduled

−$33.55K

90,910

0.0914%

$909.10K

−6.5%

Lowenthal Richard E

PRESIDENT AND CEO

—

5,523,683

5.55%

$55.24M

−10.0%

Flynn James E

10% owner

—

4,887,254

4.91%

$48.87M

−21.1%

Tanimoto Sarina

CHIEF MEDICAL OFFICER

—

4,680,959

4.71%

$46.81M

−11.6%

Shah Pratik

Director

—

4,474,554

4.50%

$44.75M

−7.3%

Shawver Laura

Director

—

210,346

0.2115%

$2.10M

0.0%

Scott Kathleen D.

Chief Financial Officer

—

10,042

0.0101%

$100.42K

0.0%

SAUNDERS BRENT L

Director

—

0.0000%

$0.00

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 23

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 1

Sales straight out of an exercise 4

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 426,828

History held since 7 Dec 2020